IFYBER LLC
Medtech · Private
Nitric oxide-releasing biomaterial wound dressing with sustained NO-delivery system
ifyber.com →- Grants
- $1.2M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $6.3M
- 12 awards · Defense, Health and Human S
- #99 of 4531 in medtech
- Patents
- 2
- 0 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2008201020122014201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Defense · SBIR Phase I | $99,999 | |
| Federal contract | Department of Defense · Research And Development In The Physical, Engineer | $69,999 | |
| Federal contract | Department of Defense · SBIR Phase I (A013-160-0457) | $69,900 | |
| Federal contract | Department of Defense · Darpa SBIR Phase I Entitled "lab-on-a-bubble: A Powerful, Low-cost, Point-of-care, Diagnostic Platform Technology" | $100,000 | |
| Federal contract | Department of Defense · #mpeg-pdha Hemostatic Agent | $11,000 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf Special Studies/analysis- Scientific Data | $197,095 | |
| Federal contract | Department of Defense · #mpeg-pdha Hemostatic Agent, | $8,000 | |
| Federal grant | Department of Health and Human Services · Phase I · A Nitric Oxide Polymer Platform for the Prevention and Treatment of Infected Wounds | $255,827 | |
| Federal grant | Department of Health and Human Services · Phase I · A Nitric Oxide Polymer Platform for the Prevention and Treatment of Infected Wounds | $255,827 | |
| Federal grant | Department of Health and Human Services · Phase I · Peptide-based wound dressing for prevention and management of infected wounds | $215,957 | |
| Federal grant | Department of Health and Human Services · Phase I · Peptide based wound dressing for prevention and management of infected wounds | $215,957 | |
| Federal contract | Department of Defense · Igf::ct::igf SBIR Phase I Award Compressive Habiliment Integrated Technology For Continuous Health Assessment Tasks | $149,837 | |
| Federal contract· 1 of 2 same day | Department of Health and Human Services · SBIR Phase I Igf::ot::ogf | $149,983 | |
| Federal contract· 2 of 2 same day | Department of Defense · Dha 2017.1 SBIR Phase II Medical R&d Contract For Proposal H2- 0331 For Project Titled,"rapid Field Testing Of Field Water Samples For Total Coliform And E. Coli Using Isothermal Amplification And Unique Micron-sized Particles For Cell Capture And Concentration" | $1,999,090 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of wound care formulations for PVP/NO: A novel nitric oxide releasing platform with potent antimicrobial and anti-biofilm properties | $299,356 | |
| Federal contract | Department of Defense · Research Medical Research And Development Dha SBIR Direct To Phase II Proposal No. H2D-0027 Titled Standard-issue Antimicrobial Combat Burn Gauze. | $2,195,570 | |
| Federal contract | Department of Defense · Defense Health Agency Sequential Phase II Sir Topic DHA201-D001 To Ifyber Llc. | $1,298,777 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 96 | DIAGNOSTICS FOR THE REAL WORLD LIMITED | $6.5M | — |
| 97 | CVD EQUIPMENT CORPORATION | $6.5M | — |
| 98 | AccuVein Inc. | $6.4M | $48M |
| 99 | IFYBER LLC | $6.3M | — |
| 100 | Axion Biosystems, Inc. | $6.3M | $21M |
| 101 | Whoop, Inc. | $6.3M | $177M |
| 102 | Electrical Geodesics, Inc. | $6.3M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Method Of Detecting An Analyte Using Coated Hollow Microspheres And Method Of Producing Sameapplication
- Method Of Detecting An Analyte Using Coated Hollow Microspheres And Method Of Producing Sameapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.